Under conditions of proteinopathy in the serum and human placenta in PE, we have demonstrated the presence of aggregated TTR, amyloid β, and cis P-tau proteins in the serum of patients with early- or late-onset severe PE16. The gene discussed is MAPT; the disease is proteostasis deficiencies.